EBS | tickerfilter.com

Fundamental analysis

16%

Profitability 2%

Dept financing 18%

Liquidity 17%

Performance 29%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-12.80%

1 Month

-29.99%

3 Months

63.26%

6 Months

159.69%

1 Year

83.04%

2 Year

-65.66%

Key data

Stock price

$8.31

P/E Ratio

-0.74

DAY RANGE

$8.05 - $10.50

EPS

-$11.31

52 WEEK RANGE

$1.42 - $15.10

52 WEEK CHANGE

$0.64

MARKET CAP

439.654 M

YIELD

N/A

SHARES OUTSTANDING

52.907 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$3,264,916

AVERAGE 30 VOLUME

$4,352,102

Company detail

CEO: Robert Kramer
Region: US
Website: https://emergentbiosolutions.com/
Employees: 2,607
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent

EBS - Emergent Biosolutions Inc